Sickle Cell Disease Treatment Global Market Report 2024

Sickle Cell Disease Treatment Global Market Report 2024 – By Treatment Modality (Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant), By Disease Type (Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types), By Route Of Administration (Oral, Parenteral), By End-User (Hospitals, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Name: Sickle Cell Disease Treatment Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Sickle Cell Disease Treatment Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Sickle Cell Disease Treatment Market Definition

Sickle cell disease (SCD), also known as sickle cell anemia, is a genetic disorder affecting hemoglobin, a protein in red blood cells. A mutation in the hemoglobin gene causes the production of defective hemoglobin, referred to as hemoglobin S (HbS), in people with sickle cell disease. The sickle cell disease treatment removes blockages, enhances blood flow and repairs damaged tissues.

The main types of treatment modalities for sickle cell disease treatment are blood transfusion, pharmacotherapy and bone marrow transplant. The transfer of blood or blood products from a donor to a recipient is known as a blood transfusion. The various disease types are sickle cell anemia, hemoglobin sickle C disease (HBsC) and others with various routes of administration such as oral and parenteral. The end users are hospitals, specialty clinics and others.

Sickle Cell Disease Treatment Market Segmentation

The sickle cell disease treatment market covered in this report is segmented –

1) By Treatment Modality: Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant

2) By Disease Type: Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC); Other Disease Types

3) By Route Of Administration: Oral; Parenteral

4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Global Sickle Cell Disease Treatment Market Size 2023 to 2028: Graph

Sickle Cell Disease Treatment Market Size 2024 And Growth Rate

The sickle cell disease treatment market size has grown rapidly in recent years. It will grow from $2.46 billion in 2023 to $2.95 billion in 2024 at a compound annual growth rate (CAGR) of 20.0%. The growth in the historic period can be attributed to disease understanding, blood transfusions, pain management, hydroxyurea therapy.

Sickle Cell Disease Treatment Market Growth Forecast

The sickle cell disease treatment market size is expected to see rapid growth in the next few years. It will grow to $5.75 billion in 2028 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to gene editing and gene therapy, new drug development, telemedicine and remote monitoring, global health initiatives. Major trends in the forecast period include curative therapies, pain management alternatives, global collaborations, patient advocacy and engagement.

Book your 30 minutes free consultation with our research experts

Sickle Cell Disease Treatment Market Driver: Rising Demand For Blood Transfusions Fuels Growth In The Sickle Cell Disease Treatment Market

The increasing demand for blood transfusions is expected to propel the growth of the sickle cell disease treatment market going forward. A blood transfusion is a medical procedure in which blood or blood products are given from one person (the donor) to another (the receiver). Blood transfusions are a crucial part of treatment for sickle cell disease (SCD) patients because they improve blood's ability to carry oxygen and lessen the difficulties associated with vaso-occlusion. For instance, in December 2022, according to gov.UK, a UK-based public sector information platform, in 2021, the number of blood donations increased, with 1.7 million donations made around the UK. Further, in January 2022, according to Mid-Atlantic Long-Term Care, a US-based provider of specialized 24-hour triage on-call service, in the US, around 29,000 units of red blood cells, 5,000 units of platelets and 6.500 units of plasma are needed every day. Therefore, the increasing demand for blood transfusions is driving the growth of the sickle cell disease treatment market.

Sickle Cell Disease Treatment Market Driver: Increasing Blood And Bone Marrow Transplants Fuel Growth In The Sickle Cell Disease Treatment Market

The rising blood and bone marrow transplant is expected to propel the growth of sickle cell disease treatment going forward. A blood and bone marrow transplant is a medical procedure that replaces unhealthy blood-forming cells with healthy ones. A bone marrow transplant aims to cure sickle cell diseases and cancers by infusing healthy bone marrow cells into a person after their sick bone marrow has been treated to remove the abnormal cells. The replacement cells are derived from the patient's own body (autologous transplant) or from a donor's body (allogeneic transplant). For instance, in June 2023, according to Health Resources and Services Administration, in 2021, 5,073 unrelated and 4,276 related bone marrow and cord blood transplants were conducted in the United States. Additionally, there were 9,285,029 registered donors of bone marrow in 2021, which rose to 9,475,534 in 2021. Thus, the rising blood and bone marrow transplant will boost the sickle cell disease treatment market.

Global Sickle Cell Disease Treatment Market Major Players

Major players in the sickle cell disease treatment market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Silver Lake Research Corporation0.45, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., Arena Pharmaceuticals Inc., Mast Therapeutics Inc.

Global Sickle Cell Disease Treatment Market Restraint: Impact Of High Medical Costs On The Growth Of The Sickle Cell Disease (SCD) Treatment Market

The high medical costs are negatively impacting the growth of the sickle cell disease treatment market during the forecast period. The high cost of medical care for individuals with SCD can create significant financial barriers. Patients and their families may struggle to afford essential treatments, medications, and hospitalizations, leading to delayed or inadequate care. For instance, in July 2022, according to the National Library of Medicine, a US-based medical library, patients with SCD had greater costs (annual cost difference: $6636-43,436) than those without SCD. Inpatient care (costing between $11,978 and $59,851 yearly) was the medical expense that affected SCD patients the most. Therefore, the high medical costs are hindering the growth of the sickle cell disease treatment market.

Global Sickle Cell Disease Treatment Market Trend: Innovative Product Approvals Drive Advancements In Sickle Cell Disease Treatment Market

Major companies operating in the sickle cell disease treatment market are focusing on adopting new product approvals to sustain their position in the market. Drug approval for sickle cell disease treatment is to provide effective treatment options for patients with this lifelong condition. For instance, in December 2021, Global Therapeutics Inc., a US-based biopharmaceutical company, announced the U.S. FDA granted rapid approval for Oxbryta (voxelotor) tablets. These tablets are used to treat sickle cell disease (SCD) in children between the ages of 4 and 11 years. For kids with SCD, Oxbryta is the only FDA-approved medication that specifically prevents sickle hemoglobin polymerization, the underlying cause of sickling and red blood cell destruction in SCD. This is a first-in-class drug that works by increasing the production of fetal hemoglobin (HbF) and it does this by binding to and activating the TNSALP enzyme. This allows the enzyme to break down pyrophosphate, a substance that can interfere with the production of HbF. Oxbryta is administered as a subcutaneous injection once daily.

Sickle Cell Disease Treatment Market Merger And Acquisition: Pfizer's Strategic Acquisition Of Global Blood Therapeutics Enhances Its Sickle Cell Disease Portfolio

In October 2022, Pfizer Inc., a US-based pharmaceutical corporation, acquired Global Blood Therapeutics Inc. for $5.4 billion. Through this acquisition, Pfizer now has access to a premier sickle cell disease portfolio and pipeline, which has the potential to address pressing needs in a patient population that is underserved. Global Blood Therapeutics Inc. is a US-based biopharmaceutical company that develops and commercializes therapies for people with sickle cell disease (SCD).

Regional Outlook For The Global Sickle Cell Disease Treatment Market

North America was the largest region in the sickle cell disease treatment market in 2023. The regions covered in sickle cell disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sickle cell disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sickle cell disease treatment market consists of revenues earned by entities by providing services such as oxygen therapy, pulmonary hypertension management and pain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The sickle cell disease treatment market also includes sales of hydroxyurea, L-glutamine and voxlelotor. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The sickle cell disease treatment market research report is one of a series of new reports from The Business Research Company that provides sickle cell disease treatment market statistics, including sickle cell disease treatment industry global market size, regional shares, competitors with a sickle cell disease treatment market share, detailed sickle cell disease treatment market segments, market trends and opportunities and any further data you may need to thrive in the sickle cell disease treatment industry. This sickle cell disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Sickle Cell Disease Treatment Market Report Scope

Report Attribute	Details
Market Size Value In 2024	$2.95 billion
Revenue Forecast In 2033	$5.75 billion
Growth Rate	CAGR of 18.1% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant 2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types 3) By Route Of Administration: Oral, Parenteral 4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; Johnson & Johnson Private Limited; Merck & Co Inc.; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Eli Lilly and Company; Gilead Sciences Inc.; Amgen Inc.; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Vertex Pharmaceuticals Incorporated; Alnylam Pharmaceuticals Inc.; Ionis Pharmaceuticals Inc.; Silver Lake Research Corporation0.45; Global Blood Therapeutics Inc.; Acceleron Pharma Inc.; Sangamo Therapeutics Inc.; Medunik USA Inc.; Zydus Cadila Healthcare Ltd.; Graphite Bio Inc.; Addmedica; Emmaus Medical Inc.; Bluebird bio Inc.; CRISPR Therapeutics AG; GlycoMimetics Inc.; Arena Pharmaceuticals Inc.; Mast Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Sickle Cell Disease Treatment Market Characteristics

3. Sickle Cell Disease Treatment Market Trends And Strategies

4. Sickle Cell Disease Treatment Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Sickle Cell Disease Treatment Market Size and Growth

5.1. Global Sickle Cell Disease Treatment Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Sickle Cell Disease Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Sickle Cell Disease Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sickle Cell Disease Treatment Market Segmentation

6.1. Global Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Blood Transfusion

Pharmacotherapy

Bone Marrow Transplant

6.2. Global Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Sickle Cell Anemia

Hemoglobin Sickle C Disease (HbSC)

Other Disease Types

6.3. Global Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oral

Parenteral

6.4. Global Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Specialty Clinics

Other End-Users

7. Sickle Cell Disease Treatment Market Regional And Country Analysis

7.1. Global Sickle Cell Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Sickle Cell Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sickle Cell Disease Treatment Market

8.1. Asia-Pacific Sickle Cell Disease Treatment Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sickle Cell Disease Treatment Market

9.1. China Sickle Cell Disease Treatment Market Overview

9.2. China Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sickle Cell Disease Treatment Market

10.1. India Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sickle Cell Disease Treatment Market

11.1. Japan Sickle Cell Disease Treatment Market Overview

11.2. Japan Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sickle Cell Disease Treatment Market

12.1. Australia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sickle Cell Disease Treatment Market

13.1. Indonesia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sickle Cell Disease Treatment Market

14.1. South Korea Sickle Cell Disease Treatment Market Overview

14.2. South Korea Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sickle Cell Disease Treatment Market

15.1. Western Europe Sickle Cell Disease Treatment Market Overview

15.2. Western Europe Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sickle Cell Disease Treatment Market

16.1. UK Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sickle Cell Disease Treatment Market

17.1. Germany Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sickle Cell Disease Treatment Market

18.5. France Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sickle Cell Disease Treatment Market

19.9. Italy Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sickle Cell Disease Treatment Market

20.13. Spain Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sickle Cell Disease Treatment Market

21.1. Eastern Europe Sickle Cell Disease Treatment Market Overview

21.2. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sickle Cell Disease Treatment Market

22.1. Russia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sickle Cell Disease Treatment Market

23.1. North America Sickle Cell Disease Treatment Market Overview

23.2. North America Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sickle Cell Disease Treatment Market

24.1. USA Sickle Cell Disease Treatment Market Overview

24.2. USA Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sickle Cell Disease Treatment Market

25.1. Canada Sickle Cell Disease Treatment Market Overview

25.2. Canada Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sickle Cell Disease Treatment Market

26.1. South America Sickle Cell Disease Treatment Market Overview

26.2. South America Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sickle Cell Disease Treatment Market

27.1. Brazil Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sickle Cell Disease Treatment Market

28.1. Middle East Sickle Cell Disease Treatment Market Overview

28.2. Middle East Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sickle Cell Disease Treatment Market

29.1. Africa Sickle Cell Disease Treatment Market Overview

29.2. Africa Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sickle Cell Disease Treatment Market Competitive Landscape And Company Profiles

30.1. Sickle Cell Disease Treatment Market Competitive Landscape

30.2. Sickle Cell Disease Treatment Market Company Profiles

30.2.1. Sun Pharmaceutical Industries Ltd.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Pfizer Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Johnson & Johnson Private Limited

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Merck & Co Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Novartis AG

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Sickle Cell Disease Treatment Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. Bristol-Myers Squibb Company

31.3. AstraZeneca plc

31.4. Eli Lilly and Company

31.5. Gilead Sciences Inc.

31.6. Amgen Inc.

31.7. Baxter International Inc.

31.8. Teva Pharmaceutical Industries Ltd.

31.9. Vertex Pharmaceuticals Incorporated

31.10. Alnylam Pharmaceuticals Inc.

31.11. Ionis Pharmaceuticals Inc.

31.12. Silver Lake Research Corporation0.45

31.13. Global Blood Therapeutics Inc.

31.14. Acceleron Pharma Inc.

31.15. Sangamo Therapeutics Inc.

32. Global Sickle Cell Disease Treatment Market Competitive Benchmarking

33. Global Sickle Cell Disease Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sickle Cell Disease Treatment Market

35. Sickle Cell Disease Treatment Market Future Outlook and Potential Analysis

35.1 Sickle Cell Disease Treatment Market In 2028 - Countries Offering Most New Opportunities

35.2 Sickle Cell Disease Treatment Market In 2028 - Segments Offering Most New Opportunities

35.3 Sickle Cell Disease Treatment Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Sickle Cell Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Sickle Cell Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Sun Pharmaceutical Industries Ltd. Financial Performance

Table 76: Pfizer Inc. Financial Performance

Table 77: Johnson & Johnson Private Limited Financial Performance

Table 78: Merck & Co Inc. Financial Performance

Table 79: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Sickle Cell Disease Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Sickle Cell Disease Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Sun Pharmaceutical Industries Ltd. Financial Performance

Figure 76: Pfizer Inc. Financial Performance

Figure 77: Johnson & Johnson Private Limited Financial Performance

Figure 78: Merck & Co Inc. Financial Performance

Figure 79: Novartis AG Financial Performance

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Global Central Lab Market 2022 – Market Opportunities And Strategies

What Is The Biohacking Market Overview In 2022?

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Blood Transfusion Diagnostics Global Market Report 2024 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Patient Blood Management Global Market Report 2024 – By Product (Instruments, Accessories, Reagents And Kits, Software), By Component (Plasma, Whole Blood, Red Blood Cells), By Application (Hospital, Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Anemia And Other Blood Disorder Drugs Global Market Report 2024 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Blood Cancer Drugs Global Market Report 2024 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Other Drugs), By Treatment Approaches (Key Findings, Chemotherapeutic, mAbs/Targeted Therapies, Immunotherapeutic) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Stem Cell/Cord Blood Banking Global Market Report 2024 – By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type (Public, Private), By Application (Leukemia, Anemia, Thalassemia, Autism, Cerebral Palsy, Diabetes, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Blood Collection Devices Global Market Report 2024 – By Type (Blood Collection Tubes, Lancet, Micro Container Tubes, Warming Devices), By Method (Manual Blood Collection, Automatic Blood Collection), By Material (Glass, Stainless Steel, Plastic), By End User (Hospitals, Blood Donation Centers, Diagnostic Center, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Blood Culture Tests Global Market Report 2024 – By Method (Conventional/Manual Methods, Automated Methods), By Product (Consumables, Instruments, Software and Services), By Technology (Culture-Based Technology, Molecular Technologies, Microarrays, PCR (Polymerase Chain Reaction), PNA-FiSH (Peptide Nucleic Acid – Fluorescent in Situ Hybridization), Proteomics Technology), By Application (Bacteremia, Fungemia, Mycobacterial Detection), By End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Blood And Blood Components Global Market Report 2024 – By Product (Whole Blood, Blood Components), By Blood Components (Red Blood Cells, Platelets, Plasma, White Blood Cells), By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Application (Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the sickle cell disease treatment market?

How will the sickle cell disease treatment market drivers and restraints affect the sickle cell disease treatment market dynamics? What forces will shape the sickle cell disease treatment industry going forward?

The sickle cell disease treatment market major growth driver - Rising Demand For Blood Transfusions Fuels Growth In The Sickle Cell Disease Treatment Market. request a sample here

What is the forecast market size or the forecast market value of the sickle cell disease treatment market?

The sickle cell disease treatment market size has grown rapidly in recent years. It will grow from $2.46 billion in 2023 to $2.95 billion in 2024 at a compound annual growth rate (CAGR) of 20.0%. The growth in the historic period can be attributed to disease understanding, blood transfusions, pain management, hydroxyurea therapy. The sickle cell disease treatment market size is expected to see rapid growth in the next few years. It will grow to $5.75 billion in 2028 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to gene editing and gene therapy, new drug development, telemedicine and remote monitoring, global health initiatives. Major trends in the forecast period include curative therapies, pain management alternatives, global collaborations, patient advocacy and engagement. request a sample here

How is the sickle cell disease treatment market segmented?

The sickle cell disease treatment market is segmented
1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant
2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Specialty Clinics, Other End-UsersFor further insights on the sickle cell disease treatment market request a sample here

Which region has the largest share of the sickle cell disease treatment market? What are the other regions covered in the report?

North America was the largest region in the sickle cell disease treatment market in 2023. The regions covered in sickle cell disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the sickle cell disease treatment market?

What are the key trends in the sickle cell disease treatment market?

Major trend in the sickle cell disease treatment market - Innovative Product Approvals Drive Advancements In Sickle Cell Disease Treatment Market. request a sample here.

What are the major opportunities in the sickle cell disease treatment market? What are the strategies for the sickle cell disease treatment market?

For detailed insights on the major opportunities and strategies in the sickle cell disease treatment market, request a sample here.

How does the sickle cell disease treatment market relate to the overall economy and other similar markets?

For detailed insights on sickle cell disease treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the sickle cell disease treatment industry?

For detailed insights on the mergers and acquisitions in the sickle cell disease treatment industry, request a sample here.

What are the key dynamics influencing the sickle cell disease treatment market growth? SWOT analysis of the sickle cell disease treatment market.

For detailed insights on the key dynamics influencing the sickle cell disease treatment market growth and SWOT analysis of the sickle cell disease treatment industry, request a sample here.